Seth Klarman: portfolio of Baupost Group

Seth Klarman leads the Baupost Group, which follows a value approach and looks for securities trading below their estimated worth.

Source: 13F filing with the US Securities and Exchange Commission dated May 14, 2021. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q1 2021. Go to the latest filing (Q3 2026)

12.5B USDQ1 2021
Total value of stock positions
12.5B USD
Positions
58
Share of the ten largest
65.0%

The ten largest positions Q1 2021

  1. Intel 11.9%▲ +28.2%
  2. Liberty Global PLC 11.1%unchanged
  3. eBay Inc. 9.0%▼ −41.1%
  4. Qorvo Inc 7.6%▲ +17.7%
  5. Viasat Inc 6.3%unchanged
  6. Alphabet Inc. (Class C) 4.8%▲ +265.6%
  7. Willis Towers Watson 4.6%new
  8. Micron Technology 3.8%▲ +3.9%
  9. Meta Platforms 3.0%▲ +41.0%
  10. PG&E Corporation 2.9%unchanged
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 12.7B USD).
Choose a quarter (54 filings)

All positions Q1 2021

Positions Q1 2021 per 13F filing, 58 of 58
Symbol Weight Shares Reported value Change Held since
Viasat Inc 6.3% 16,288,959 783.0M USD unchanged Q2 2013 or earlier 32 quarters
Theravance Biopharma Inc 1.4% 8,735,168 178.3M USD unchanged Q2 2014 28 quarters
Veritiv Corp 1.2% 3,564,439 151.6M USD unchanged Q3 2014 27 quarters
Atara Biotherapeutics Inc 1.0% 8,477,488 121.7M USD −6.9% reduced Q4 2014 26 quarters
Trilogy Metals Inc New 0.2% 12,182,568 26.1M USD unchanged Q3 2016 19 quarters
Qorvo Inc 7.6% 5,224,466 954.5M USD +17.7% increased Q1 2017 17 quarters
PCG PG&E Corporation 2.9% 30,657,601 359.0M USD unchanged Q1 2018 13 quarters
Translate Bio Inc 2.4% 18,044,239 295.8M USD unchanged Q2 2018 12 quarters
Colony Cap Inc New 1.3% 24,212,959 156.9M USD unchanged Q2 2018 12 quarters
Liberty Global PLC 11.1% 54,555,407 1.4B USD unchanged Q3 2018 11 quarters
Liberty Global PLC 1.6% 7,657,205 196.5M USD unchanged Q3 2018 11 quarters
EBAY eBay Inc. 9.0% 18,324,423 1.1B USD −41.1% reduced Q4 2018 10 quarters
Nexstar Media Group Inc 2.3% 2,085,000 292.8M USD unchanged Q4 2018 10 quarters
FOXA Fox Corporation (Class A) 2.2% 7,610,818 274.8M USD −65.7% reduced Q1 2019 9 quarters
FOX Fox Corporation (Class B) 1.6% 5,680,307 198.4M USD unchanged Q1 2019 9 quarters
GOOG Alphabet Inc. (Class C) 4.8% 290,930 601.8M USD +265.6% increased Q1 2020 5 quarters
META Meta Platforms 3.0% 1,297,000 382.0M USD +41.0% increased Q1 2020 5 quarters
Liberty Media Corp Del 2.3% 6,484,867 286.0M USD unchanged Q1 2020 5 quarters
SS&C Technologies HLDGS Inc 2.1% 3,806,892 266.0M USD +15.2% increased Q2 2020 4 quarters
Verint Sys Inc 1.1% 3,039,798 138.3M USD +32.7% increased Q2 2020 4 quarters
MU Micron Technology 3.8% 5,423,416 478.4M USD +3.9% increased Q3 2020 3 quarters
Pershing Square Tontine Hldg 2.4% 12,707,924 305.1M USD unchanged Q3 2020 3 quarters
DOC Healthpeak Properties 1.3% 4,966,911 157.7M USD +24.2% increased Q3 2020 3 quarters
Liberty Media Corp Del 1.2% 3,500,000 154.3M USD unchanged Q3 2020 3 quarters
Pershing Square Tontine Hldg 0.1% 1,944,444 15.8M USD unchanged Q3 2020 3 quarters
INTC Intel 11.9% 23,305,334 1.5B USD +28.2% increased Q4 2020 2 quarters
Advantage Solutions Inc 1.1% 12,500,000 143.6M USD unchanged Q4 2020 2 quarters
Fidelity National Financial 1.0% 3,036,935 123.5M USD −20.1% reduced Q4 2020 2 quarters
Dragoneer Growth Oppty Corp < 0.1% 1,000,000 10.3M USD unchanged Q4 2020 2 quarters
Vesper Healthcare Acqstn Cor < 0.1% 1,320,000 2.7M USD unchanged Q4 2020 2 quarters
Redball Acquisition Corp < 0.1% 1,650,000 2.2M USD unchanged Q4 2020 2 quarters
WTW Willis Towers Watson 4.6% 2,500,000 572.2M USD new Q1 2021 1 quarter
IFF International Flavors & Fragrances 2.3% 2,100,000 293.2M USD new Q1 2021 1 quarter
Nuvation Bio Inc 0.7% 8,623,021 82.4M USD new Q1 2021 1 quarter
Cullinan Oncology Inc 0.6% 1,835,560 71.7M USD new Q1 2021 1 quarter
Reinvent Technology Partners 0.5% 6,000,000 60.2M USD new Q1 2021 1 quarter
Ajax I 0.4% 5,000,000 51.3M USD new Q1 2021 1 quarter
Thoma Bravo Advantage 0.3% 4,000,000 41.8M USD new Q1 2021 1 quarter
Avanti Acquisition Corp 0.3% 4,000,000 39.1M USD new Q1 2021 1 quarter
Horizon Acquisition Corporat 0.3% 3,499,998 35.7M USD new Q1 2021 1 quarter
Reinvent Technology Partners 0.3% 3,500,000 35.5M USD new Q1 2021 1 quarter
Liberty Media Acquisition Co 0.3% 3,200,000 32.4M USD new Q1 2021 1 quarter
Broadstone Acquisition Corp 0.2% 2,970,000 29.1M USD new Q1 2021 1 quarter
Altimeter Growth Corp 2 0.2% 2,500,000 26.0M USD new Q1 2021 1 quarter
Investindustrial Acquisition 0.2% 2,100,000 20.5M USD new Q1 2021 1 quarter
Dragoneer Growth Opt Corp II 0.2% 2,000,000 20.2M USD new Q1 2021 1 quarter
Finch Therapeutics Group Inc 0.2% 1,208,159 18.9M USD new Q1 2021 1 quarter
Svf Investment Corp < 0.1% 1,000,000 10.2M USD new Q1 2021 1 quarter
Reinvent Technology Partners < 0.1% 1,000,000 10.0M USD new Q1 2021 1 quarter
Horizon Acquisition Corporat < 0.1% 1,166,666 2.4M USD new Q1 2021 1 quarter
Ajax I < 0.1% 1,250,000 2.1M USD new Q1 2021 1 quarter
Avanti Acquisition Corp < 0.1% 2,000,000 2.1M USD new Q1 2021 1 quarter
Liberty Media Acquisition Co < 0.1% 640,000 1.9M USD new Q1 2021 1 quarter
Reinvent Technology Partners < 0.1% 875,000 1.8M USD new Q1 2021 1 quarter
Broadstone Acquisition Corp < 0.1% 1,485,000 1.0M USD new Q1 2021 1 quarter
Investindustrial Acquisition < 0.1% 700,000 574.0K USD new Q1 2021 1 quarter
Svf Investment Corp < 0.1% 200,000 414.0K USD new Q1 2021 1 quarter
Reinvent Technology Partners < 0.1% 200,000 316.0K USD new Q1 2021 1 quarter

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Plus 1 position in convertible bonds and bonds worth 30.6M USD as reported – not included in the weights.

Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.

  • Theravance Biopharma Inc principal 30.0M USD 30.6M USD

Breakdown by sector

  • Technology 15.7%
  • Communication Services 11.6%
  • Consumer Discretionary 9.0%
  • Financials 4.6%
  • Utilities 2.9%
  • Materials 2.3%
  • Real Estate 1.3%
  • not in our coverage 52.7%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close